

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 9.93851995 |
| 2 | lung secretory cell differentiation (GO:0061140) | 9.59419998 |
| 3 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 8.12292614 |
| 4 | maintenance of gastrointestinal epithelium (GO:0030277) | 8.11813602 |
| 5 | regulation of norepinephrine secretion (GO:0014061) | 7.75462840 |
| 6 | hepatocyte apoptotic process (GO:0097284) | 7.20960023 |
| 7 | sulfation (GO:0051923) | 6.85306638 |
| 8 | regulation of guanylate cyclase activity (GO:0031282) | 6.78556223 |
| 9 | glandular epithelial cell differentiation (GO:0002067) | 6.63041919 |
| 10 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.55713872 |
| 11 | regulation of cellular extravasation (GO:0002691) | 6.15912562 |
| 12 | epithelial structure maintenance (GO:0010669) | 6.11513764 |
| 13 | NADH metabolic process (GO:0006734) | 5.92652138 |
| 14 | bile acid metabolic process (GO:0008206) | 5.90167925 |
| 15 | mucosal immune response (GO:0002385) | 5.66932892 |
| 16 | complement activation, classical pathway (GO:0006958) | 5.53255943 |
| 17 | intestinal absorption (GO:0050892) | 5.49768221 |
| 18 | positive regulation of pseudopodium assembly (GO:0031274) | 5.46889684 |
| 19 | antibacterial humoral response (GO:0019731) | 5.44706777 |
| 20 | negative regulation of cell fate commitment (GO:0010454) | 5.42242923 |
| 21 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.38323402 |
| 22 | organ or tissue specific immune response (GO:0002251) | 5.37229714 |
| 23 | antimicrobial humoral response (GO:0019730) | 5.32653601 |
| 24 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.30868520 |
| 25 | positive regulation of respiratory burst (GO:0060267) | 5.29914208 |
| 26 | regulation of hormone biosynthetic process (GO:0046885) | 5.11093279 |
| 27 | positive regulation of cytokine production involved in immune response (GO:0002720) | 5.04984718 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.02731159 |
| 29 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.96064828 |
| 30 | regulation of pseudopodium assembly (GO:0031272) | 4.93337955 |
| 31 | glomerular filtration (GO:0003094) | 4.78780524 |
| 32 | epoxygenase P450 pathway (GO:0019373) | 4.75090911 |
| 33 | galactose metabolic process (GO:0006012) | 4.71303545 |
| 34 | complement activation (GO:0006956) | 4.57722580 |
| 35 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.54179589 |
| 36 | regulation of bile acid biosynthetic process (GO:0070857) | 4.53352019 |
| 37 | digestive system process (GO:0022600) | 4.51732143 |
| 38 | positive regulation of glucose import (GO:0046326) | 4.50636865 |
| 39 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.42219833 |
| 40 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.42219833 |
| 41 | endocrine process (GO:0050886) | 4.42219833 |
| 42 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.41356514 |
| 43 | O-glycan processing (GO:0016266) | 4.37839088 |
| 44 | lung cell differentiation (GO:0060479) | 4.35879131 |
| 45 | lung epithelial cell differentiation (GO:0060487) | 4.31967457 |
| 46 | leukocyte tethering or rolling (GO:0050901) | 4.31945283 |
| 47 | renal filtration (GO:0097205) | 4.31405255 |
| 48 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.30769855 |
| 49 | regulation of cGMP biosynthetic process (GO:0030826) | 4.30261233 |
| 50 | cellular response to fatty acid (GO:0071398) | 4.26589365 |
| 51 | hormone catabolic process (GO:0042447) | 4.26335531 |
| 52 | regulation of viral entry into host cell (GO:0046596) | 4.21426757 |
| 53 | urea cycle (GO:0000050) | 4.19948501 |
| 54 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.19664561 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19118598 |
| 56 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 4.12678081 |
| 57 | lipoprotein transport (GO:0042953) | 4.10459849 |
| 58 | N-acetylglucosamine metabolic process (GO:0006044) | 4.09871519 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06275921 |
| 60 | urea metabolic process (GO:0019627) | 4.04546958 |
| 61 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.03626794 |
| 62 | regulation of systemic arterial blood pressure (GO:0003073) | 4.01926627 |
| 63 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.00183135 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 3.99354086 |
| 65 | virion attachment to host cell (GO:0019062) | 3.99354086 |
| 66 | positive regulation of acute inflammatory response (GO:0002675) | 3.93496825 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.93015945 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92616826 |
| 69 | peptide catabolic process (GO:0043171) | 3.89437499 |
| 70 | regulation of keratinocyte proliferation (GO:0010837) | 3.85953189 |
| 71 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.85646056 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.83583231 |
| 73 | arginine metabolic process (GO:0006525) | 3.81987088 |
| 74 | nitrogen cycle metabolic process (GO:0071941) | 3.80432988 |
| 75 | positive regulation of cell fate commitment (GO:0010455) | 3.79986559 |
| 76 | positive regulation of glucose transport (GO:0010828) | 3.78203253 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 3.73481239 |
| 78 | galactose catabolic process (GO:0019388) | 3.73361000 |
| 79 | regulation of hormone metabolic process (GO:0032350) | 3.70400141 |
| 80 | regulation of cytokine production involved in immune response (GO:0002718) | 3.67485603 |
| 81 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.67076484 |
| 82 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.61546144 |
| 83 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.60622147 |
| 84 | regulation of cGMP metabolic process (GO:0030823) | 3.59521055 |
| 85 | protein activation cascade (GO:0072376) | 3.58703673 |
| 86 | membrane tubulation (GO:0097320) | 3.51201309 |
| 87 | drug metabolic process (GO:0017144) | 3.50711937 |
| 88 | nucleotide transmembrane transport (GO:1901679) | 3.49780466 |
| 89 | ethanol oxidation (GO:0006069) | 3.46951664 |
| 90 | peptide hormone processing (GO:0016486) | 3.45430701 |
| 91 | regulation of podosome assembly (GO:0071801) | 3.43279835 |
| 92 | renal system process involved in regulation of blood volume (GO:0001977) | 3.42333598 |
| 93 | adhesion of symbiont to host (GO:0044406) | 3.41827306 |
| 94 | vitamin A metabolic process (GO:0006776) | 3.39308571 |
| 95 | regulation of vitamin metabolic process (GO:0030656) | 3.36696382 |
| 96 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.36180400 |
| 97 | arginine catabolic process (GO:0006527) | 3.32599999 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 3.32532494 |
| 99 | digestion (GO:0007586) | 3.29813839 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.26795380 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26795380 |
| 102 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.26213471 |
| 103 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.25166752 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.24657549 |
| 105 | GDP-mannose metabolic process (GO:0019673) | 3.23843657 |
| 106 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.20765207 |
| 107 | cardiac conduction (GO:0061337) | 3.20015904 |
| 108 | cGMP-mediated signaling (GO:0019934) | 3.17450818 |
| 109 | transcytosis (GO:0045056) | 3.17386421 |
| 110 | actin filament depolymerization (GO:0030042) | 3.16785239 |
| 111 | regulation of actin nucleation (GO:0051125) | 3.16666837 |
| 112 | glutathione derivative biosynthetic process (GO:1901687) | 3.09797911 |
| 113 | glutathione derivative metabolic process (GO:1901685) | 3.09797911 |
| 114 | glucuronate metabolic process (GO:0019585) | 3.08142053 |
| 115 | uronic acid metabolic process (GO:0006063) | 3.08142053 |
| 116 | cellular glucuronidation (GO:0052695) | 3.06091922 |
| 117 | vitamin transmembrane transport (GO:0035461) | 3.04822090 |
| 118 | diacylglycerol metabolic process (GO:0046339) | 3.04781997 |
| 119 | alkaloid metabolic process (GO:0009820) | 3.03751261 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.03400004 |
| 121 | glycolipid catabolic process (GO:0019377) | 3.03224402 |
| 122 | eosinophil chemotaxis (GO:0048245) | 3.02308092 |
| 123 | response to nitric oxide (GO:0071731) | 3.01347169 |
| 124 | glycosphingolipid catabolic process (GO:0046479) | 3.01117028 |
| 125 | positive regulation of chemokine production (GO:0032722) | 3.01070993 |
| 126 | humoral immune response (GO:0006959) | 2.99170146 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98574363 |
| 128 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.97451209 |
| 129 | monocarboxylic acid transport (GO:0015718) | 2.97309911 |
| 130 | negative regulation of epidermis development (GO:0045683) | 2.97152367 |
| 131 | glucose 6-phosphate metabolic process (GO:0051156) | 2.96837815 |
| 132 | signal peptide processing (GO:0006465) | 2.96436484 |
| 133 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.95269406 |
| 134 | sexual reproduction (GO:0019953) | 2.93961185 |
| 135 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90298370 |
| 136 | cysteine metabolic process (GO:0006534) | 2.90226458 |
| 137 | negative regulation of viral transcription (GO:0032897) | 2.89769573 |
| 138 | drug catabolic process (GO:0042737) | 2.89282826 |
| 139 | regulation of catecholamine secretion (GO:0050433) | 2.83356056 |
| 140 | oligosaccharide biosynthetic process (GO:0009312) | 2.83126640 |
| 141 | cyclooxygenase pathway (GO:0019371) | 2.83095174 |
| 142 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.82945554 |
| 143 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.80932514 |
| 144 | positive regulation of cGMP metabolic process (GO:0030825) | 2.80539914 |
| 145 | angiotensin maturation (GO:0002003) | 2.80266239 |
| 146 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.79544833 |
| 147 | regulation of respiratory burst (GO:0060263) | 2.79188094 |
| 148 | exogenous drug catabolic process (GO:0042738) | 2.73546233 |
| 149 | glucosamine-containing compound metabolic process (GO:1901071) | 2.73163101 |
| 150 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 2.73021607 |
| 151 | cellular response to nutrient (GO:0031670) | 2.72576521 |
| 152 | regulation of cholesterol esterification (GO:0010872) | 2.72103586 |
| 153 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.71733255 |
| 154 | desmosome organization (GO:0002934) | 2.71551951 |
| 155 | midgut development (GO:0007494) | 2.69933778 |
| 156 | regulation of water loss via skin (GO:0033561) | 2.69588687 |
| 157 | positive regulation of lipid catabolic process (GO:0050996) | 2.69578849 |
| 158 | base-excision repair, AP site formation (GO:0006285) | 2.69530909 |
| 159 | fructose metabolic process (GO:0006000) | 2.69438856 |
| 160 | keratinocyte development (GO:0003334) | 2.68415715 |
| 161 | eosinophil migration (GO:0072677) | 2.67860986 |
| 162 | receptor catabolic process (GO:0032801) | 2.67087710 |
| 163 | negative regulation of actin filament depolymerization (GO:0030835) | 2.65159977 |
| 164 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.63432765 |
| 165 | actin filament capping (GO:0051693) | 2.63328421 |
| 166 | sulfur amino acid catabolic process (GO:0000098) | 2.62616520 |
| 167 | glutathione biosynthetic process (GO:0006750) | 2.60170977 |
| 168 | lipoprotein metabolic process (GO:0042157) | 2.59576515 |
| 169 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.59173415 |
| 170 | regulation of glucose import (GO:0046324) | 2.58984770 |
| 171 | negative regulation of blood pressure (GO:0045776) | 2.56330874 |
| 172 | protein O-linked glycosylation (GO:0006493) | 2.55774917 |
| 173 | amino sugar metabolic process (GO:0006040) | 2.52194459 |
| 174 | regulation of cholesterol homeostasis (GO:2000188) | 2.51097802 |
| 175 | regulation of monocyte chemotaxis (GO:0090025) | 2.51022576 |
| 176 | regulation of cholesterol metabolic process (GO:0090181) | 2.50972094 |
| 177 | negative regulation by host of viral transcription (GO:0043922) | 2.47267214 |
| 178 | regulation of cellular amide metabolic process (GO:0034248) | 2.45788902 |
| 179 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.43168922 |
| 180 | killing of cells of other organism (GO:0031640) | 2.42198299 |
| 181 | disruption of cells of other organism (GO:0044364) | 2.42198299 |
| 182 | bile acid and bile salt transport (GO:0015721) | 10.8508724 |
| 183 | intestinal epithelial cell development (GO:0060576) | 10.0074134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.22743378 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.13329334 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.85780743 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.85308825 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.77133300 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.57947158 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.87521508 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.67417813 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.58425965 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.54144475 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.52819811 |
| 12 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.49680430 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40990917 |
| 14 | STAT1_20625510_ChIP-Seq_HELA_Human | 2.37087007 |
| 15 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.29549276 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.23158173 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22237811 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.16518685 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07421651 |
| 20 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.05548024 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.01635656 |
| 22 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.00924656 |
| 23 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.98732595 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95590773 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.95391187 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93176697 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.92626251 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91488775 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89922987 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89127285 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.82277824 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78093909 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68661187 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.66650874 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56474944 |
| 36 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.56347512 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54049956 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50364432 |
| 39 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.47773804 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45949294 |
| 41 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.43000683 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42617865 |
| 43 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41011616 |
| 44 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.36367546 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35477201 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35451964 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35298775 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34791142 |
| 49 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30966630 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30918594 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28403738 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27379334 |
| 53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26918136 |
| 54 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25661403 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.25153293 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25146903 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25086968 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24466569 |
| 59 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24285415 |
| 60 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22665054 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22271467 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22235485 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21599598 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21269865 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.19367098 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18702697 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18589861 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17478835 |
| 69 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.17342342 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17061674 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16761756 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15716325 |
| 73 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14881130 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14575410 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12824506 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12697829 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07716581 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06760567 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04880350 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04720095 |
| 81 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.03370172 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03264208 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02261572 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01662814 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00706186 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00468937 |
| 87 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99965818 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99608016 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98732405 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98650280 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96912649 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96323619 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95803176 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94519704 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94014791 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93432512 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.93012752 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91656194 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90916628 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90488518 |
| 101 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90472302 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89924989 |
| 103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89283687 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87595577 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87566274 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87561373 |
| 107 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87323206 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87034675 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86898858 |
| 110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86264471 |
| 111 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85970628 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85624808 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85527280 |
| 114 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85355464 |
| 115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84932783 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84078659 |
| 117 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82675040 |
| 118 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82222828 |
| 119 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81282382 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80827346 |
| 121 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80793361 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80451185 |
| 123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80289470 |
| 124 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80010539 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79589782 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79442242 |
| 127 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79185755 |
| 128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78926394 |
| 129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78280423 |
| 130 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.77923970 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77823703 |
| 132 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.77609953 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76642027 |
| 134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.76585842 |
| 135 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75090354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003868_abnormal_feces_composition | 6.23752228 |
| 2 | MP0005360_urolithiasis | 5.13521063 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.23438091 |
| 4 | MP0005666_abnormal_adipose_tissue | 3.85862010 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.53941318 |
| 6 | MP0001873_stomach_inflammation | 3.33294141 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.32909249 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.32558004 |
| 9 | MP0010155_abnormal_intestine_physiology | 3.31238170 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 3.15190372 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 3.09857183 |
| 12 | MP0003866_abnormal_defecation | 2.91169939 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.85270172 |
| 14 | MP0004858_abnormal_nervous_system | 2.78312220 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 2.72857042 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.71906188 |
| 17 | MP0003252_abnormal_bile_duct | 2.63677942 |
| 18 | MP0000490_abnormal_crypts_of | 2.60527708 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.58167162 |
| 20 | MP0005365_abnormal_bile_salt | 2.48601462 |
| 21 | MP0001663_abnormal_digestive_system | 2.46053966 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.40578146 |
| 23 | MP0000477_abnormal_intestine_morphology | 2.37298741 |
| 24 | MP0003011_delayed_dark_adaptation | 2.34528612 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.32799480 |
| 26 | MP0005375_adipose_tissue_phenotype | 2.25196791 |
| 27 | MP0001664_abnormal_digestion | 2.19969480 |
| 28 | MP0000462_abnormal_digestive_system | 2.11548151 |
| 29 | MP0005381_digestive/alimentary_phenotyp | 2.09783498 |
| 30 | MP0005409_darkened_coat_color | 2.06905075 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 2.04518098 |
| 32 | MP0005165_increased_susceptibility_to | 1.92521309 |
| 33 | MP0005451_abnormal_body_composition | 1.90966511 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.87881006 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 1.86762899 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.68859509 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.66052484 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.51367779 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.50749727 |
| 40 | MP0004147_increased_porphyrin_level | 1.50450275 |
| 41 | MP0001849_ear_inflammation | 1.50333986 |
| 42 | MP0000537_abnormal_urethra_morphology | 1.49986813 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.45981203 |
| 44 | MP0005448_abnormal_energy_balance | 1.42834704 |
| 45 | MP0003329_amyloid_beta_deposits | 1.42501289 |
| 46 | MP0001764_abnormal_homeostasis | 1.42089366 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.39297561 |
| 48 | MP0005377_hearing/vestibular/ear_phenot | 1.32914329 |
| 49 | MP0003878_abnormal_ear_physiology | 1.32914329 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.29937435 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.29478552 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.28501201 |
| 53 | MP0005334_abnormal_fat_pad | 1.27349095 |
| 54 | MP0003879_abnormal_hair_cell | 1.22496854 |
| 55 | MP0009840_abnormal_foam_cell | 1.22319860 |
| 56 | MP0005387_immune_system_phenotype | 1.20674792 |
| 57 | MP0001790_abnormal_immune_system | 1.20674792 |
| 58 | MP0000604_amyloidosis | 1.20157826 |
| 59 | MP0009785_altered_susceptibility_to | 1.17206922 |
| 60 | MP0002136_abnormal_kidney_physiology | 1.15845658 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.14118957 |
| 62 | MP0001835_abnormal_antigen_presentation | 1.12457881 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.09760802 |
| 64 | MP0002971_abnormal_brown_adipose | 1.08937625 |
| 65 | MP0005025_abnormal_response_to | 1.07760343 |
| 66 | MP0001756_abnormal_urination | 1.07736614 |
| 67 | MP0006054_spinal_hemorrhage | 1.03989976 |
| 68 | MP0001958_emphysema | 1.01992906 |
| 69 | MP0005670_abnormal_white_adipose | 1.01750674 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.98529526 |
| 71 | MP0002822_catalepsy | 0.97688998 |
| 72 | MP0010678_abnormal_skin_adnexa | 0.97321378 |
| 73 | MP0003724_increased_susceptibility_to | 0.94124786 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.93462424 |
| 75 | MP0001188_hyperpigmentation | 0.92411306 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90629428 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.90396625 |
| 78 | MP0004859_abnormal_synaptic_plasticity | 0.86993465 |
| 79 | MP0000249_abnormal_blood_vessel | 0.86641720 |
| 80 | MP0005166_decreased_susceptibility_to | 0.84665647 |
| 81 | MP0002796_impaired_skin_barrier | 0.84308548 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.82719728 |
| 83 | MP0002933_joint_inflammation | 0.82602228 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.81703574 |
| 85 | MP0005535_abnormal_body_temperature | 0.80507086 |
| 86 | MP0002896_abnormal_bone_mineralization | 0.80095608 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.79089975 |
| 88 | MP0000685_abnormal_immune_system | 0.78929891 |
| 89 | MP0000470_abnormal_stomach_morphology | 0.78894252 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.77100091 |
| 91 | MP0005023_abnormal_wound_healing | 0.76834767 |
| 92 | MP0008469_abnormal_protein_level | 0.75709069 |
| 93 | MP0002006_tumorigenesis | 0.75201728 |
| 94 | MP0003075_altered_response_to | 0.75157893 |
| 95 | MP0004043_abnormal_pH_regulation | 0.75145844 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.73629134 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.72950360 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.72931346 |
| 99 | MP0009764_decreased_sensitivity_to | 0.72289870 |
| 100 | MP0003091_abnormal_cell_migration | 0.71736428 |
| 101 | MP0003448_altered_tumor_morphology | 0.71694633 |
| 102 | MP0002098_abnormal_vibrissa_morphology | 0.70026954 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.69813660 |
| 104 | MP0010307_abnormal_tumor_latency | 0.69749065 |
| 105 | MP0001440_abnormal_grooming_behavior | 0.68209146 |
| 106 | MP0000609_abnormal_liver_physiology | 0.67949750 |
| 107 | MP0004885_abnormal_endolymph | 0.67804804 |
| 108 | MP0004947_skin_inflammation | 0.67397349 |
| 109 | MP0001881_abnormal_mammary_gland | 0.66487053 |
| 110 | MP0002148_abnormal_hypersensitivity_rea | 0.64883518 |
| 111 | MP0009053_abnormal_anal_canal | 0.64060334 |
| 112 | MP0004270_analgesia | 0.64024346 |
| 113 | MP0003303_peritoneal_inflammation | 0.63773216 |
| 114 | MP0009115_abnormal_fat_cell | 0.62539156 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.60156983 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.59696167 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.59562275 |
| 118 | MP0008004_abnormal_stomach_pH | 0.58502243 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.58084114 |
| 120 | MP0008872_abnormal_physiological_respon | 0.57976660 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.57500188 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.55082074 |
| 123 | MP0005332_abnormal_amino_acid | 0.53287123 |
| 124 | MP0003828_pulmonary_edema | 0.53263605 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.52495257 |
| 126 | MP0003436_decreased_susceptibility_to | 0.52261840 |
| 127 | MP0005671_abnormal_response_to | 0.51523156 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.51433193 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.50404337 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.50290200 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.49843891 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.49210299 |
| 133 | MP0000467_abnormal_esophagus_morphology | 0.48546584 |
| 134 | MP0000383_abnormal_hair_follicle | 0.48323793 |
| 135 | MP0008873_increased_physiological_sensi | 0.45776304 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.45700991 |
| 137 | MP0009931_abnormal_skin_appearance | 0.45090001 |
| 138 | MP0005275_abnormal_skin_tensile | 0.43137816 |
| 139 | MP0006082_CNS_inflammation | 0.42242801 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.41324037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.67942615 |
| 2 | Micronodular cirrhosis (HP:0001413) | 6.78497787 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.86062004 |
| 4 | Complement deficiency (HP:0004431) | 5.38563249 |
| 5 | Abnormality of complement system (HP:0005339) | 5.12049360 |
| 6 | Ileus (HP:0002595) | 4.90411281 |
| 7 | Bundle branch block (HP:0011710) | 4.79715499 |
| 8 | Glomerulonephritis (HP:0000099) | 4.77087826 |
| 9 | Abdominal distention (HP:0003270) | 4.50437895 |
| 10 | Esophageal varix (HP:0002040) | 4.42867401 |
| 11 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.33968799 |
| 12 | Abnormality of vitamin B metabolism (HP:0004340) | 4.09140008 |
| 13 | Syncope (HP:0001279) | 4.05349432 |
| 14 | Abnormality of vitamin metabolism (HP:0100508) | 3.74520987 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.73102655 |
| 16 | Nephritis (HP:0000123) | 3.72834560 |
| 17 | Woolly hair (HP:0002224) | 3.62822733 |
| 18 | Malnutrition (HP:0004395) | 3.51825189 |
| 19 | Hyperparathyroidism (HP:0000843) | 3.33471988 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.32429548 |
| 21 | Prolonged QT interval (HP:0001657) | 3.32228727 |
| 22 | Hemorrhage of the eye (HP:0011885) | 3.25063935 |
| 23 | Pigmentary retinal degeneration (HP:0001146) | 3.22677199 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.22520939 |
| 25 | Fat malabsorption (HP:0002630) | 3.19742906 |
| 26 | Glycosuria (HP:0003076) | 3.17713906 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 3.17713906 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.17634907 |
| 29 | Decreased circulating renin level (HP:0003351) | 3.15508873 |
| 30 | Hypoplastic ischia (HP:0003175) | 3.10782361 |
| 31 | Xanthomatosis (HP:0000991) | 3.07813413 |
| 32 | Exocrine pancreatic insufficiency (HP:0001738) | 3.02878876 |
| 33 | Abnormal foot bone ossification (HP:0010675) | 3.01900919 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.00341228 |
| 35 | Oligomenorrhea (HP:0000876) | 2.99234681 |
| 36 | Alkalosis (HP:0001948) | 2.83735391 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.81635382 |
| 38 | Metabolic alkalosis (HP:0200114) | 2.77683861 |
| 39 | Wide cranial sutures (HP:0010537) | 2.71365604 |
| 40 | Abnormality of the ischium (HP:0003174) | 2.67466975 |
| 41 | Hypercortisolism (HP:0001578) | 2.67453585 |
| 42 | Chronic diarrhea (HP:0002028) | 2.62478176 |
| 43 | Hyperactive renin-angiotensin system (HP:0000841) | 2.62165765 |
| 44 | Hyperlipoproteinemia (HP:0010980) | 2.61664986 |
| 45 | Hypobetalipoproteinemia (HP:0003563) | 2.61164430 |
| 46 | Confusion (HP:0001289) | 2.58824515 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58584692 |
| 48 | Atrophic scars (HP:0001075) | 2.58131020 |
| 49 | Abnormality of the gastric mucosa (HP:0004295) | 2.58073346 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.55605039 |
| 51 | Dysmetric saccades (HP:0000641) | 2.50495057 |
| 52 | Facial shape deformation (HP:0011334) | 2.48844118 |
| 53 | Potter facies (HP:0002009) | 2.48844118 |
| 54 | Palpitations (HP:0001962) | 2.48176228 |
| 55 | Villous atrophy (HP:0011473) | 2.47935339 |
| 56 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.47935339 |
| 57 | Hyperglycinuria (HP:0003108) | 2.46860885 |
| 58 | Protuberant abdomen (HP:0001538) | 2.46694384 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.44549132 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.44549132 |
| 61 | Nephrolithiasis (HP:0000787) | 2.44353289 |
| 62 | Abnormal atrioventricular conduction (HP:0005150) | 2.43369962 |
| 63 | Heart block (HP:0012722) | 2.41440105 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.39644397 |
| 65 | Hyperammonemia (HP:0001987) | 2.37734433 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.37278118 |
| 67 | Increased purine levels (HP:0004368) | 2.36978281 |
| 68 | Hyperuricemia (HP:0002149) | 2.36978281 |
| 69 | Conjugated hyperbilirubinemia (HP:0002908) | 2.36653000 |
| 70 | Multiple lipomas (HP:0001012) | 2.36132299 |
| 71 | Abnormality of renin-angiotensin system (HP:0000847) | 2.35811935 |
| 72 | Posterior subcapsular cataract (HP:0007787) | 2.34389966 |
| 73 | Nausea (HP:0002018) | 2.33309631 |
| 74 | Rectal prolapse (HP:0002035) | 2.32150789 |
| 75 | Hypophosphatemia (HP:0002148) | 2.31992180 |
| 76 | Emphysema (HP:0002097) | 2.31292116 |
| 77 | Congenital, generalized hypertrichosis (HP:0004540) | 2.29127318 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.27949934 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.27501880 |
| 80 | Cerebral palsy (HP:0100021) | 2.26509999 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.25028067 |
| 82 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25028067 |
| 83 | Growth hormone excess (HP:0000845) | 2.23408140 |
| 84 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.22037250 |
| 85 | Abnormal vertebral ossification (HP:0100569) | 2.20511719 |
| 86 | Pancreatitis (HP:0001733) | 2.19916263 |
| 87 | Late onset (HP:0003584) | 2.19156729 |
| 88 | Gingivitis (HP:0000230) | 2.17433781 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.16106136 |
| 90 | Abnormality of glycolysis (HP:0004366) | 2.16106136 |
| 91 | Hypolipoproteinemia (HP:0010981) | 2.14771153 |
| 92 | Abnormal pancreas size (HP:0012094) | 2.14739470 |
| 93 | Hypotension (HP:0002615) | 2.14444338 |
| 94 | Abnormality of the nasal mucosa (HP:0000433) | 2.11131795 |
| 95 | Hyperphosphaturia (HP:0003109) | 2.08030583 |
| 96 | Gastrointestinal dysmotility (HP:0002579) | 2.07548181 |
| 97 | Orchitis (HP:0100796) | 2.07308877 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.05237887 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.03164256 |
| 100 | Onycholysis (HP:0001806) | 2.03065658 |
| 101 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02345827 |
| 102 | Focal segmental glomerulosclerosis (HP:0000097) | 2.01472494 |
| 103 | Subcapsular cataract (HP:0000523) | 2.00425415 |
| 104 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.98283353 |
| 105 | Colitis (HP:0002583) | 1.97060968 |
| 106 | Ventricular fibrillation (HP:0001663) | 1.97003280 |
| 107 | Milia (HP:0001056) | 1.93848738 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 1.92810280 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92810280 |
| 110 | Bradycardia (HP:0001662) | 1.91088523 |
| 111 | Deep venous thrombosis (HP:0002625) | 1.89504884 |
| 112 | Renal Fanconi syndrome (HP:0001994) | 1.89092991 |
| 113 | Hyperphosphatemia (HP:0002905) | 1.88635464 |
| 114 | Thin bony cortex (HP:0002753) | 1.88010917 |
| 115 | Flat acetabular roof (HP:0003180) | 1.86033335 |
| 116 | Acanthocytosis (HP:0001927) | 1.85127289 |
| 117 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84640580 |
| 118 | Action tremor (HP:0002345) | 1.84442923 |
| 119 | Short clavicles (HP:0000894) | 1.83985751 |
| 120 | Subacute progressive viral hepatitis (HP:0006572) | 1.83351486 |
| 121 | Amyloidosis (HP:0011034) | 1.83106754 |
| 122 | Abnormality of abdominal situs (HP:0011620) | 1.82758112 |
| 123 | Abdominal situs inversus (HP:0003363) | 1.82758112 |
| 124 | Abnormal EKG (HP:0003115) | 1.81924311 |
| 125 | Cholecystitis (HP:0001082) | 1.81563661 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 1.81563661 |
| 127 | Steatorrhea (HP:0002570) | 1.79396345 |
| 128 | Abnormal tarsal ossification (HP:0008369) | 1.78590599 |
| 129 | Recurrent bronchitis (HP:0002837) | 1.78248162 |
| 130 | Abnormal glucose tolerance (HP:0001952) | 1.77860654 |
| 131 | Hypoglycemic coma (HP:0001325) | 1.77745034 |
| 132 | Myokymia (HP:0002411) | 1.77297278 |
| 133 | Fragile nails (HP:0001808) | 1.76979246 |
| 134 | Increased muscle lipid content (HP:0009058) | 1.76433596 |
| 135 | Delayed epiphyseal ossification (HP:0002663) | 1.75345097 |
| 136 | Rhabdomyolysis (HP:0003201) | 1.75049647 |
| 137 | Hypoalphalipoproteinemia (HP:0003233) | 1.74403846 |
| 138 | Peritonitis (HP:0002586) | 1.74036673 |
| 139 | Vasculitis (HP:0002633) | 1.73313965 |
| 140 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73031806 |
| 141 | Failure to thrive in infancy (HP:0001531) | 1.72642383 |
| 142 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72030739 |
| 143 | Insulin resistance (HP:0000855) | 1.71386631 |
| 144 | Epidermoid cyst (HP:0200040) | 1.71074464 |
| 145 | Bone cyst (HP:0012062) | 1.70602712 |
| 146 | Widely patent fontanelles and sutures (HP:0004492) | 1.69853140 |
| 147 | Toxemia of pregnancy (HP:0100603) | 1.69712951 |
| 148 | Epileptic encephalopathy (HP:0200134) | 1.69674145 |
| 149 | Germ cell neoplasia (HP:0100728) | 1.68968447 |
| 150 | Ventricular arrhythmia (HP:0004308) | 1.68964975 |
| 151 | Premature loss of primary teeth (HP:0006323) | 1.67368921 |
| 152 | Megaloblastic anemia (HP:0001889) | 1.66415319 |
| 153 | Skin rash (HP:0000988) | 1.66204883 |
| 154 | Bone pain (HP:0002653) | 1.66080213 |
| 155 | Metabolic acidosis (HP:0001942) | 1.65194571 |
| 156 | Skin nodule (HP:0200036) | 1.64395289 |
| 157 | Purpura (HP:0000979) | 1.63133171 |
| 158 | Pili torti (HP:0003777) | 1.61982165 |
| 159 | Spontaneous hematomas (HP:0007420) | 1.61077756 |
| 160 | Renal tubular acidosis (HP:0001947) | 1.60203171 |
| 161 | Glomerulosclerosis (HP:0000096) | 1.59605128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.63779601 |
| 2 | NME1 | 6.34808911 |
| 3 | RPS6KB2 | 5.03062354 |
| 4 | ACVR1B | 4.78737935 |
| 5 | STK24 | 3.28288401 |
| 6 | FGFR4 | 3.05545655 |
| 7 | TEC | 2.98561227 |
| 8 | EPHA3 | 2.71025804 |
| 9 | MST4 | 2.69292655 |
| 10 | ERN1 | 2.58056449 |
| 11 | EEF2K | 2.43518799 |
| 12 | LMTK2 | 2.39671763 |
| 13 | TYK2 | 2.29099823 |
| 14 | PTK6 | 2.28941527 |
| 15 | EPHA2 | 2.15759124 |
| 16 | EPHB1 | 2.14684649 |
| 17 | BLK | 2.12010075 |
| 18 | TAOK1 | 2.04201134 |
| 19 | LATS1 | 2.03824468 |
| 20 | MAP2K2 | 1.97177091 |
| 21 | EPHB2 | 1.90501477 |
| 22 | TAOK3 | 1.80626340 |
| 23 | MST1R | 1.68373596 |
| 24 | TRIB3 | 1.62799360 |
| 25 | PIK3CA | 1.62569065 |
| 26 | CDC42BPA | 1.55833394 |
| 27 | TGFBR2 | 1.50118375 |
| 28 | FGFR3 | 1.47039101 |
| 29 | CAMK2D | 1.43396888 |
| 30 | PRPF4B | 1.41286225 |
| 31 | MAP3K11 | 1.40283846 |
| 32 | PRKG2 | 1.39003670 |
| 33 | CAMK2B | 1.37507422 |
| 34 | TESK2 | 1.31438339 |
| 35 | GRK1 | 1.27481051 |
| 36 | TESK1 | 1.26034221 |
| 37 | NLK | 1.18949974 |
| 38 | MAP3K2 | 1.18496127 |
| 39 | MAP3K7 | 1.16313681 |
| 40 | MAP2K1 | 1.14310083 |
| 41 | GRK6 | 1.08072038 |
| 42 | OXSR1 | 1.04606007 |
| 43 | JAK1 | 1.03455695 |
| 44 | KSR2 | 1.03289158 |
| 45 | PDK2 | 1.00989926 |
| 46 | CSK | 0.99208376 |
| 47 | CAMK2G | 0.98887868 |
| 48 | PDGFRA | 0.98149066 |
| 49 | ZAP70 | 0.97856956 |
| 50 | PKN2 | 0.97450485 |
| 51 | DMPK | 0.96742057 |
| 52 | MATK | 0.95286336 |
| 53 | FER | 0.94716154 |
| 54 | MAP3K6 | 0.92574238 |
| 55 | MAP3K10 | 0.91254370 |
| 56 | PAK4 | 0.90183935 |
| 57 | ILK | 0.86370066 |
| 58 | CAMK1 | 0.81320482 |
| 59 | PDPK1 | 0.79612990 |
| 60 | IKBKE | 0.77779404 |
| 61 | IRAK1 | 0.77729731 |
| 62 | MAP3K1 | 0.76228246 |
| 63 | KIT | 0.75300519 |
| 64 | MAP3K12 | 0.74195542 |
| 65 | PTK2 | 0.73839088 |
| 66 | JAK3 | 0.73802435 |
| 67 | NUAK1 | 0.73771139 |
| 68 | LRRK2 | 0.73277849 |
| 69 | AKT3 | 0.70688097 |
| 70 | TRPM7 | 0.68764281 |
| 71 | JAK2 | 0.67792496 |
| 72 | CDK12 | 0.67583106 |
| 73 | MAP3K8 | 0.63690073 |
| 74 | CSNK1G3 | 0.62362969 |
| 75 | PRKACG | 0.61748520 |
| 76 | ITK | 0.59223950 |
| 77 | ABL2 | 0.57776447 |
| 78 | RET | 0.57208475 |
| 79 | PAK3 | 0.55907816 |
| 80 | MYLK | 0.55670947 |
| 81 | CSNK1A1L | 0.54930433 |
| 82 | TNIK | 0.52276026 |
| 83 | MAP3K3 | 0.51445759 |
| 84 | MAPK11 | 0.50696782 |
| 85 | MAPKAPK3 | 0.50005837 |
| 86 | LIMK1 | 0.49592267 |
| 87 | SMG1 | 0.49109402 |
| 88 | CSNK1G2 | 0.48508822 |
| 89 | BMX | 0.48469227 |
| 90 | STK10 | 0.47100675 |
| 91 | MAPKAPK2 | 0.46889875 |
| 92 | RIPK1 | 0.46879544 |
| 93 | ERBB2 | 0.46856052 |
| 94 | PRKCE | 0.46324893 |
| 95 | PDK1 | 0.44453210 |
| 96 | CDK19 | 0.43914610 |
| 97 | PRKCQ | 0.42712788 |
| 98 | CSNK1A1 | 0.41844724 |
| 99 | RIPK4 | 0.40929296 |
| 100 | MAP3K14 | 0.40397029 |
| 101 | PRKCZ | 0.39827703 |
| 102 | CSF1R | 0.39800174 |
| 103 | EPHA4 | 0.38013513 |
| 104 | FYN | 0.36825058 |
| 105 | MAPK7 | 0.36696829 |
| 106 | CLK1 | 0.36620293 |
| 107 | KDR | 0.36539672 |
| 108 | DYRK1B | 0.35980589 |
| 109 | SRC | 0.35093196 |
| 110 | HIPK2 | 0.34309160 |
| 111 | ALK | 0.33909928 |
| 112 | MAPKAPK5 | 0.31959936 |
| 113 | CAMK2A | 0.31533120 |
| 114 | TBK1 | 0.31523181 |
| 115 | PRKAA2 | 0.30873439 |
| 116 | YES1 | 0.30274152 |
| 117 | SYK | 0.30140323 |
| 118 | IGF1R | 0.30007511 |
| 119 | CSNK1G1 | 0.29990115 |
| 120 | MET | 0.29980785 |
| 121 | MAP4K1 | 0.29736692 |
| 122 | PRKCA | 0.29475165 |
| 123 | PDGFRB | 0.28882037 |
| 124 | ERBB4 | 0.28184494 |
| 125 | PRKCD | 0.28040117 |
| 126 | BCR | 0.27345323 |
| 127 | LYN | 0.27261555 |
| 128 | RPS6KC1 | 0.26725647 |
| 129 | RPS6KL1 | 0.26725647 |
| 130 | CDK6 | 0.26536311 |
| 131 | PAK1 | 0.26222167 |
| 132 | BTK | 0.25730051 |
| 133 | LCK | 0.25172264 |
| 134 | TAOK2 | 0.24404075 |
| 135 | PAK6 | 0.24278954 |
| 136 | PDK3 | 0.23215119 |
| 137 | PDK4 | 0.23215119 |
| 138 | CAMKK1 | 0.22319588 |
| 139 | MAP2K6 | 0.22260741 |
| 140 | HCK | 0.21119433 |
| 141 | DDR2 | 0.19751754 |
| 142 | ICK | 0.18508750 |
| 143 | PIM2 | 0.17868906 |
| 144 | RPS6KA2 | 0.17690176 |
| 145 | STK39 | 0.15894571 |
| 146 | PRKCI | 0.15837842 |
| 147 | PAK2 | 0.13652468 |
| 148 | AKT2 | 0.13252813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 5.73352813 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.13522682 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.24771870 |
| 4 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 3.07216745 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 3.01940240 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.94273806 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 2.62376637 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23851083 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.18922317 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.06006152 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.00409408 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.83478380 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80378859 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78771721 |
| 15 | Mineral absorption_Homo sapiens_hsa04978 | 1.78255330 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74563542 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73870548 |
| 18 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.63868683 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.60762773 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.60754471 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59376935 |
| 22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.55454170 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54316478 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51956864 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45666360 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.42655655 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40391205 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38292512 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33462849 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31758251 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29736564 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25653091 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25393690 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24443391 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23038794 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17884096 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16353772 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 1.13846507 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09416573 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03556009 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02331260 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01034128 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97376256 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.96234459 |
| 45 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95111916 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93603198 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93152466 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92837378 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91177766 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90804161 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85587033 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85569725 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84213771 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81482524 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.81380905 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79865281 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78759316 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78625688 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77903719 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77436751 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75892599 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74836841 |
| 63 | * alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72337500 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71621117 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69325603 |
| 66 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.68724958 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68704805 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68345952 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.67874417 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67273032 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.66135403 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63464723 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63249507 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.62171832 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59591013 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59253964 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58633350 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58612075 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56137498 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54248735 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53620408 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.53452534 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53235716 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52949382 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52478210 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51069496 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.49465076 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47884282 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47185260 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.44915346 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.44029594 |
| 92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43181970 |
| 93 | Protein export_Homo sapiens_hsa03060 | 0.42245391 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41919292 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41914737 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41871632 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.41434745 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40762325 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40634887 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40621462 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39686391 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39608632 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39335746 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38586710 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.38276614 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37737724 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.37105183 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37030929 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35218860 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34581513 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33753332 |
| 112 | Tuberculosis_Homo sapiens_hsa05152 | 0.33717945 |
| 113 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31340532 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31169846 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31168743 |
| 116 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29774168 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29482010 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28779480 |
| 119 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27683745 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27666368 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27576041 |
| 122 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27387414 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.27036315 |
| 124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.26956686 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.26532090 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26410916 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24931218 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24798841 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23709786 |
| 130 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.23142733 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22521334 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22130054 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.21503844 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.20461494 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18805048 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18692903 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.18561160 |
| 138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18155683 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.18011262 |
| 140 | Phagosome_Homo sapiens_hsa04145 | 0.16294402 |
| 141 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.14301463 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14030507 |
| 143 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13749115 |

